Joseph Wolk has been announced as NYSE-listed Johnson & Johnson’s new vice president of IR, starting in August. He will succeed Louise Mehrotra, the firm’s long-standing IRO, who is retiring at the end of the year.
‘A proven leader’ in the firm’s finance function, according to a press release announcing Mehrotra’s succession, Wolk joined the New Jersey-headquartered firm in 1998 as a finance manager in the Ortho-McNeil Pharmaceutical organization.
He has since served in various senior financial positions at Johnson & Johnson including vice president of finance for the medical devices global supply chain and CFO of the North America pharmaceuticals group, and was most recently vice president of group finance for the pharmaceuticals division.
The St Joseph’s University and Temple University School of Law graduate started his career at electronic and electro-mechanical devices manufacturer Ametek.
‘We are confident [Joseph] will continue our commitment to transparent and credible engagement with the investment community,’ comments CFO Dominic Caruso in the release. ‘His cross-sector expertise, prudent financial management and focus on talent development will ensure the investor relations function at Johnson & Johnson remains best in class.’
Mehrotra has been with Johnson & Johnson since 1980 and has led the IR function for more than 10 years. Her team was distinguished as one of IR Magazine’s Global Top 50 in 2014.
